期刊文献+

高危型人乳头瘤病毒检测在宫颈不典型鳞状细胞患者临床管理中的作用

Effect of high risk human papillomavirus detection in clinical management of patients with cervical atypical squamous cells
下载PDF
导出
摘要 目的:探讨高危型人乳头瘤病毒(HR HPV)检测在临床管理宫颈不典型鳞状细胞中的作用。方法:采用第二代杂交捕获法(HC2)对268例宫颈细胞学检查为诊断意义不明的不典型鳞状细胞(ASCUS)的患者进行HR HPV检测,同时行阴道镜检查及病理活检,分析高危型人乳头瘤病毒感染与宫颈病变关系及临床中对ASCUS患者的管理。结果:268例患者中,病理组织学为炎症121例(45.2%),宫颈上皮内瘤变(CIN)Ⅰ97例(36.19%),CINⅡ27例(10.07%),CINⅢ19例(7.09%),宫颈浸润癌4例(1.49%),其中HR HPV阳性率53.36%(143例),CIN及以上病变在阳性组中检出率82.00%(118例),明显高于阴性组23.86%(29例),与CIN及宫颈癌有明显相关性,HPV阳性组ASCUS病例的CIN检出率明显高于HPV阴性组,差异有统计学意义(P<0.01)。结论:HR HPV检测对分流ASCUS中的高危人群有重要的临床意义,对阳性者做进一步的阴道镜检查与活检是明确诊断的较好路径,阴性者可随访观察。 Objective:To explore the effect of high risk human papillomavirus detection in clinical management of patients with cervical atypical squamous cells.Methods:268 cases with atypical squamous cells(ASCUS) whose diagnosis were unclear with cervical cytology were given HR HPV detection with the second generation of hybrid capture(HC2),at the same time,they were given colposcopy and biopsy.We analyzed the relationship of high-risk HPV infection with cervical lesions and the management of ASCUS patients in clinic.Results:In 268 cases,histopathology was inflammation in 121 cases(45.2%),97 cases(36.19%) were CIN Ⅰ,27 cases(10.07%) were CIN Ⅱ,19 cases(7.09%) were CIN Ⅲ,4 cases(1.49%) were invasive cervical cancer.Among them, the positive rate of HR HPV was 53.36%(143 cases).The positive detection rate of CIN and above lesions in the positive group was 82%(118 cases).It was significantly higher than that in the negative group of 23.86%(29 cases),and had a significant correlation with CIN and cervical cancer.The positive rate of CIN of ASCUS cases in the HPV positive group was significantly higher than that in HPV negative group,and the difference was statistically significant(P<0.01).Conclusion:HR HPV detection has important clinical significance for shunting high-risk groups in ASCUS.It is a better path for clear diagnosis of positive patients with colposcopy and biopsy.Negative people can be observed.
作者 邓远征
出处 《中国社区医师(医学专业)》 2014年第16期122-123,共2页
关键词 高危型人乳头瘤病毒 不典型鳞状细胞 管理 High risk human papilloma virus Atypical squamous cells Administration
  • 相关文献

参考文献5

二级参考文献28

  • 1石一复,李娟清.重视子宫颈疾病的防治[J].中国实用妇科与产科杂志,2004,20(7):385-386. 被引量:131
  • 2韩萍,章文华.人乳头状瘤病毒感染与子宫颈癌发病关系的探讨[J].中华妇产科杂志,1995,30(10):608-610. 被引量:140
  • 3耿力.HPV的检测及其临床应用[J].中国医刊,2007,42(8):26-28. 被引量:8
  • 4The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses.National Cancer Institute Workshop[J].JAMA,1989,262(7):931.
  • 5KINNEY W K,MANOS M M,HURLEY L B,et al.Where's the high grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses[J].Obstet Gynecol,1998,91(6):973-976.
  • 6HUGHES S A,SUN D,GIBSON C,et al.Managing atypical squamous cells of undetermined significance (ASCUS):human papillom avirus testing,ASCUS subtyping,or follow up cytology[J]? Am J Obstet Gynecol,2002,186(3):396-403.
  • 7JONES H W,3rd.Clinical treatment of women with atypical squamous cells of undetermined significance or atypical glandular cells of undetermined significance cervical cytology[J].Clini Obstet Gynecol,2000,43(2):381-393.
  • 8Klinkhamer PJ,Meerding WJ,Rosier PF,et al.Liquid-based cervical cytology[J].Cancer,2003,99 (5):263-271.
  • 9Nuovo J,Melnikow J,Howell LP.New tests for cervical cancer screening[J].Am Fam Physician,2001,64(5):729-730.
  • 10Herbest AL.The Bethesda system for reporting cervical/vaginal cytological diagnoses[J].Clin Obstet Gynecol,1992,35 (1):22-27.

共引文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部